APOA5 Produkte
(Apolipoprotein A-V (APOA5))
Kategorien
The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte APOA5 Kategorien
APOA5 Antikörper
High quality antibodies with extensive validation data.
APOA5 ELISA Kits
Reliable ELISA kits for a wide range of species.
APOA5 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene APOA5 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IHC, IP, ICC
Validierungen
- (5)
Kat. Nr.
ABIN7434506
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IHC, IP, ICC
Validierungen
- (5)
Kat. Nr.
ABIN7427942
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Mouse
Applikation
WB, IHC, IP, ICC
Validierungen
- (3)
Kat. Nr.
ABIN7438598
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene APOA5 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Competition ELISA
Validierungen
- (4)
- (1)
Kat. Nr.
ABIN6973943
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Mouse
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6999564
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Rat
Analytical Method
Quantitative Competition ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6975302
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene APOA5 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
- (1)
Kat. Nr.
ABIN1345336
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Mouse
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN7273849
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
Kat. Nr.
ABIN7508205
Menge
10 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren APOA5 Produkten
: "Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin." in: Journal of the Endocrine Society, Vol. 5, Issue 2, pp. bvaa191, (2021) (PubMed).: "Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study." in: Journal of cellular and molecular medicine, Vol. 21, Issue 6, pp. 1106-1116, (2018) (PubMed).
: "Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes." in: Molecular medicine reports, Vol. 16, Issue 5, pp. 6771-6779, (2018) (PubMed).
: "A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients." in: PLoS ONE, Vol. 12, Issue 12, pp. e0186693, (2018) (PubMed).
: "Apolipoprotein A-V is not a major determinant of triglyceride levels during human sepsis." in: Journal of critical care, Vol. 30, Issue 4, pp. 727-31, (2015) (PubMed).
: "Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 27, Issue 8, pp. 3354-62, (2013) (PubMed).
: "APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate." in: Nutrition, metabolism, and cardiovascular diseases : NMCD, Vol. 22, Issue 9, pp. 756-62, (2012) (PubMed).
: "APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels." in: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 46, Issue 6, pp. 773-7, (2008) (PubMed).
: "Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. ..." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 10, pp. 1866-71, (2008) (PubMed).
: "APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study." in: Journal of molecular medicine (Berlin, Germany), Vol. 85, Issue 2, pp. 119-28, (2007) (PubMed).
Synonyme und alternative Namen zu APOA5
apolipoprotein A5 (APOA5), apolipoprotein A-V (Apoa5), apolipoprotein A5 (Apoa5), apolipoprotein A5 L homeolog (apoa5.L), apolipoprotein A5 (apoa5), 1300007O05Rik, apo-AV, apoA-V, apoa-v, APOA5, APOAV, Apoav, apoav, MGC140487, RAP3, rap3Bezeichner auf Proteinebene für APOA5
- apo-AV
- apolipoprotein A5
- regeneration-associated protein 3
- apoA-V
- apolipoprotein AV
- apolipoprotein A-V
Sie sind hier:
